imiquimod has been researched along with Asthma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerps, S; Hvidtfeldt, M; Menzel, M; Nieto-Fontarigo, JJ; Porsbjerg, C; Ramu, S; Sander, AF; Sverrild, A; Tillgren, S; Uller, L | 1 |
| Adner, M; Cardell, LO; Fuchs, B; Kumlien Georén, S; Larsson, OJ; Manson, ML; Starkhammar, M | 1 |
| Chen, Y; Chiu, V; Do, K; Garthwaite, L; Herbert, C; Kumar, RK; Traini, D; Young, PM | 1 |
| Chen, Z; Du, Q; Gu, XY; Huang, M; Yin, KS; Zhou, LF | 1 |
| Aniscenko, J; Bartlett, NW; Black, JL; Burgess, JK; Glanville, N; Johnston, SL; King, NJ; Kuo, C; Lim, S; Oliver, BG; Walton, RP; Zhu, J | 1 |
| Carroll, ML; Davies, JM; Kirkegard, D; Li, H; Poh, AM; Towers, M; Upham, JW | 1 |
| Hengge, UR; Meykadeh, N | 1 |
| Bian, T; Jin, SX; Sun, PL; Yin, KS | 1 |
| Bian, T; De, W; Hu, JJ; Jin, SX; Ma, XQ; Yin, KS; Zhang, XL; Zhou, JY | 1 |
| Bian, T; Jin, SX; Wang, X; Wu, QZ; Yao, X; Yin, KS | 1 |
10 other study(ies) available for imiquimod and Asthma
| Article | Year |
|---|---|
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
Topics: Adjuvants, Immunologic; Adult; Aged; Angiotensin-Converting Enzyme 2; Asthma; Bronchi; Cells, Cultured; COVID-19; Female; Humans; Imiquimod; Interferon-beta; Male; Middle Aged; Respiratory Mucosa; SARS-CoV-2 | 2021 |
The TLR7 agonist imiquimod induces bronchodilation via a nonneuronal TLR7-independent mechanism: a possible role for quinoline in airway dilation.
Topics: Aminoquinolines; Animals; Asthma; Bronchioles; Bronchodilator Agents; Calcium Signaling; Cells, Cultured; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Imiquimod; Male; Myocytes, Smooth Muscle; Toll-Like Receptor 7 | 2016 |
Allergic environment enhances airway epithelial pro-inflammatory responses to rhinovirus infection.
Topics: Aminoquinolines; Asthma; Cells, Cultured; Cytokines; Epithelial Cells; Gene Expression Regulation; Humans; Imiquimod; Inflammation Mediators; Interferon Inducers; Picornaviridae Infections; Poly I-C; Respiratory Mucosa; Rhinovirus; RNA, Double-Stranded; RNA, Messenger; Th2 Cells; Toll-Like Receptor 3; Toll-Like Receptor 7 | 2017 |
Imiquimod, a toll-like receptor 7 ligand, inhibits airway remodelling in a murine model of chronic asthma.
Topics: Adaptation, Physiological; Adjuvants, Immunologic; Aminoquinolines; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chronic Disease; Cytokines; Female; Gene Expression Regulation; Hydroxyproline; Imiquimod; Immunoglobulin E; Inflammation; Lung; Mice; Mice, Inbred BALB C; Transforming Growth Factor beta1 | 2009 |
Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo.
Topics: Airway Remodeling; Aminoquinolines; Animals; Asthma; Bronchi; Cells, Cultured; Collagen Type V; Extracellular Matrix; Extracellular Matrix Proteins; Female; Humans; Imiquimod; Mice; Picornaviridae Infections; Poly I-C; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2011 |
Budesonide and formoterol reduce early innate anti-viral immune responses in vitro.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Asthma; Bronchodilator Agents; Budesonide; Cells, Cultured; Chemokine CXCL10; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Ethanolamines; Female; Formoterol Fumarate; Humans; Imiquimod; Immunity, Innate; Interferon-alpha; Interleukin-6; Leukocytes, Mononuclear; Male; Middle Aged; Rhinovirus; Toll-Like Receptor 7 | 2011 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |
Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice.
Topics: Aminoquinolines; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Chemokine CCL17; Chemokine CCL22; Chemokines, CC; Cytokines; Flow Cytometry; Imiquimod; Interleukin-4; Male; Mice; Mice, Inbred BALB C; RNA, Messenger; Signal Transduction; STAT6 Transcription Factor | 2006 |
Treatment of allergic airway inflammation and hyperresponsiveness by imiquimod modulating transcription factors T-bet and GATA-3.
Topics: Administration, Inhalation; Aminoquinolines; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Cytokines; Eosinophils; GATA3 Transcription Factor; Gene Expression Regulation; Imiquimod; Lung; Male; Ovalbumin; Rats; Rats, Sprague-Dawley; RNA, Messenger; T-Box Domain Proteins; Transcription Factors | 2006 |
[The effects of imiquimod on an animal model of asthma].
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Asthma; Disease Models, Animal; GATA3 Transcription Factor; Imiquimod; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; T-Box Domain Proteins; Th1 Cells; Th2 Cells | 2007 |